Cargando…

Risk factors for hospital-acquired antimicrobial-resistant infection caused by Acinetobacter baumannii

BACKGROUND: Acinetobacter baumannii can cause serious healthcare-associated infections (HAIs) and the incidence is increasing, with many strains now resistant to multiple antibiotic classes. The aims of this study were to examine factors associated with HAIs caused by antimicrobial-resistant as comp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ellis, Darcy, Cohen, Bevin, Liu, Jianfang, Larson, Elaine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600331/ https://www.ncbi.nlm.nih.gov/pubmed/26457183 http://dx.doi.org/10.1186/s13756-015-0083-2

Ejemplares similares

Temporal trends and risk factors for extended-spectrum beta-lactamase-producing Escherichia coli in adults with catheter-associated urinary tract infections
por: Spadafino, Joseph T, et al.
Publicado: (2014)

885 Challenges Associated with Using Biomedical Big Data for Research on Healthcare-Associated and Community-Acquired Infections
por: Cohen, Bevin, et al.
Publicado: (2014)

Clinical experience with tigecycline in the treatment of hospital-acquired pneumonia caused by multidrug resistant Acinetobacter baumannii
por: Zhou, Yangang, et al.
Publicado: (2019)

An outbreak of carbapenem-resistant Acinetobacter baumannii in a COVID-19 dedicated hospital
por: Gottesman, Tamar, et al.
Publicado: (2021)

Hospital Acquired Antibiotic-Resistant Acinetobacter Baumannii Infections in a 400-Bed Hospital in Tehran, Iran
por: Vahdani, Parviz, et al.
Publicado: (2011)

Prediction of the Risk of Hospital Deaths in Patients with Hospital-Acquired Pneumonia Caused by Multidrug-Resistant Acinetobacter baumannii Infection: A Multi-Center Study
por: Shu, Hongmei, et al.
Publicado: (2020)

A Case of Community-Acquired Pneumonia Caused by Multidrug-Resistant Acinetobacter baumannii in Korea
por: Son, Young Woong, et al.
Publicado: (2017)

Acinetobacter baumannii from grass: novel but non-resistant clones
por: Mateo-Estrada, Valeria, et al.
Publicado: (2023)

2393. Dimensions of Cumulative Antibiotic Exposure and Risk of Hospital Onset Clostridiodes Difficile
por: Song, Jiyoun, et al.
Publicado: (2019)

Pandrug-Resistant Acinetobacter baumannii Causing Nosocomial Infections in a University Hospital, Taiwan
por: Hsueh, Po-Ren, et al.
Publicado: (2002)

Carbapenem-Resistant Acinetobacter baumannii in U.S. Hospitals: Diversification of Circulating Lineages and Antimicrobial Resistance
por: Iovleva, Alina, et al.
Publicado: (2022)

Community-acquired pneumonia infections by Acinetobacter baumannii: How does alcohol impact the antimicrobial functions of macrophages?
por: Eugenin, Eliseo A
Publicado: (2013)

Increase of Carbapenem-Resistant Acinetobacter baumannii Infection in Acute Care Hospitals in Taiwan: Association with Hospital Antimicrobial Usage
por: Su, Chiu-Hsia, et al.
Publicado: (2012)

The Association Between the Frequency of Interruptions in Antibiotic Exposure and the Risk of Health Care-Associated Clostridiodes difficile Infection
por: Song, Jiyoun, et al.
Publicado: (2020)

Phage Therapy for a Multidrug-Resistant Acinetobacter baumannii Craniectomy Site Infection
por: LaVergne, Stephanie, et al.
Publicado: (2018)

Risk factors for pneumonia caused by antimicrobial drug-resistant or drug-sensitive Acinetobacter baumannii infections: A retrospective study
por: Wu, Feng, et al.
Publicado: (2020)

Assessment of Effective Antimicrobial Regimens and Mortality-Related Risk Factors for Bloodstream Infections Caused by Carbapenem-Resistant Acinetobacter baumannii
por: Gu, Shumin, et al.
Publicado: (2023)

The Involvement of the csy1 Gene in the Antimicrobial Resistance of Acinetobacter baumannii
por: Guo, Tingting, et al.
Publicado: (2022)

Clinical impact of COVID-19 in patients with carbapenem-resistant Acinetobacter baumannii bacteraemia
por: Kim, Jeong Yeon, et al.
Publicado: (2023)

Molecular epidemiology and drug resistance of Acinetobacter baumannii isolated from a regional hospital in the Brazilian Amazon region
por: Ribeiro, Edlainny Araujo, et al.
Publicado: (2020)

Comparison between bacteremia caused by carbapenem resistant Acinetobacter baumannii and Acinetobacter nosocomialis
por: Yang, Ya-Sung, et al.
Publicado: (2013)

Outcomes and prognostic factors of tigecycline treatment for hospital-acquired pneumonia involving multidrug-resistant Acinetobacter baumannii
por: Liu, Ben, et al.
Publicado: (2020)

Molecular epidemiological study of clinical Acinetobacter baumannii isolates: phenotype switching of antibiotic resistance
por: Chen, Chang-Hua, et al.
Publicado: (2013)

Epidemiological Monitoring of Nosocomial Infections Caused by Acinetobacter Baumannii
por: Custovic, Amer, et al.
Publicado: (2014)

Risk factors for acquiring Acinetobacter baumannii infection in the intensive care unit: experience from a Moroccan hospital
por: Benaissa, Elmostafa, et al.
Publicado: (2023)

Multidrug-Resistant Acinetobacter baumannii
por: Abbo, Aharon, et al.
Publicado: (2005)

Multidrug-Resistant Acinetobacter baumannii
por: Krcmery, Vladimir, et al.
Publicado: (2007)

Carbapenem-resistant Acinetobacter baumannii outbreak at university hospital
por: Takagi, E.H., et al.
Publicado: (2009)

Multidrug-resistant Acinetobacter baumannii as an emerging concern in hospitals
por: Ibrahim, Susan, et al.
Publicado: (2021)

Computational screening of antimicrobial peptides for Acinetobacter baumannii
por: Majumder, Ayan, et al.
Publicado: (2019)

The resistance mechanisms of b-lactam antimicrobials in clinical isolates of Acinetobacter baumannii
por: Kwon, Na Young, et al.
Publicado: (2002)

Development of Antimicrobial Therapy Methods to Overcome the Antibiotic Resistance of Acinetobacter baumannii
por: Kisil, O. V., et al.
Publicado: (2020)

An Acinetobacter non-baumannii Population Study: Antimicrobial Resistance Genes (ARGs)
por: Baraka, Adam, et al.
Publicado: (2020)

Systematic Review of Antimicrobial Combination Options for Pandrug-Resistant Acinetobacter baumannii
por: Karakonstantis, Stamatis, et al.
Publicado: (2021)

Novel Antimicrobial Peptide “Octoprohibitin” against Multidrug Resistant Acinetobacter baumannii
por: Jayathilaka, E. H. T. Thulshan, et al.
Publicado: (2022)

Associations between β-Lactamase Types of Acinetobacter baumannii and Antimicrobial Resistance
por: Černiauskienė, Kristina, et al.
Publicado: (2023)

CRISPR-Based Gene Editing in Acinetobacter baumannii to Combat Antimicrobial Resistance
por: Junaid, Muhammad, et al.
Publicado: (2023)

Detection of antibiotic resistant Acinetobacter baumannii in various hospital environments: potential sources for transmission of Acinetobacter infections
por: Shamsizadeh, Zahra, et al.
Publicado: (2017)

The Mechanisms of Disease Caused by Acinetobacter baumannii
por: Morris, Faye C., et al.
Publicado: (2019)

High lethality rate of carbapenem-resistant Acinetobacter baumannii in Intensive Care Units of a Brazilian hospital: An epidemiologic surveillance study
por: Kurihara, Mariana Neri Lucas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_furh5ge6v4aandunp32em1cvq7